186 related articles for article (PubMed ID: 16913519)
1. Provision of bloodborne virus screening in substance misuse.
Harniman B
Nurs Times; 2006 Aug 1-7; 102(31):28-30. PubMed ID: 16913519
[TBL] [Abstract][Full Text] [Related]
2. Bloodborne and sexually transmitted infections in drug users in a hospital in Buenos Aires, Argentina.
Moscatello G; Campello P; Benetucci JA
Clin Infect Dis; 2003 Dec; 37 Suppl 5():S343-7. PubMed ID: 14648444
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
Achakzai M; Kassi M; Kasi PM
Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
[TBL] [Abstract][Full Text] [Related]
4. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
6. Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus, and hepatitis C virus infections among Bulgarian injection drug users.
Vassilev ZP; Hagan H; Lyubenova A; Tomov N; Vasilev G; Krasteva D; Des Jarlais DC
Int J STD AIDS; 2006 Sep; 17(9):621-6. PubMed ID: 16942654
[TBL] [Abstract][Full Text] [Related]
7. Audit of bloodborne virus infections in injecting drug users in general practice.
Peat M; Budd J; Burns SM; Robertson R
Commun Dis Public Health; 2000 Dec; 3(4):244-6. PubMed ID: 11280250
[TBL] [Abstract][Full Text] [Related]
8. Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.
Day C; White B; Ross J; Dolan K
Aust N Z J Public Health; 2003 Oct; 27(5):558. PubMed ID: 14651407
[No Abstract] [Full Text] [Related]
9. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
10. Improving blood-borne viral diagnosis; clinical audit of the uptake of dried blood spot testing offered by a substance misuse service.
Craine N; Parry J; O'Toole J; D'Arcy S; Lyons M
J Viral Hepat; 2009 Mar; 16(3):219-22. PubMed ID: 19175879
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis services at an injecting drug user outreach clinic.
Moriarty H; Kemp R; Robinson G
N Z Med J; 2001 Mar; 114(1128):105-6. PubMed ID: 11346154
[TBL] [Abstract][Full Text] [Related]
12. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
13. Bloodborne pathogens. What you need to know--Part II.
Twitchell KT
AAOHN J; 2003 Feb; 51(2):89-97; quiz 98-9. PubMed ID: 12655983
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of perceptions of hepatitis B and C status. Value of screening for hepatitis C is still debatable.
Suckling R; Perrett K; McKendrick M
BMJ; 2000 Feb; 320(7233):513. PubMed ID: 10722302
[No Abstract] [Full Text] [Related]
15. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
16. Incidence of bloodborne virus infection and risk behaviours in a cohort of injecting drug users in Victoria, 1990-1995.
Crofts N; Aitken CK
Med J Aust; 1997 Jul; 167(1):17-20. PubMed ID: 9236754
[TBL] [Abstract][Full Text] [Related]
17. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
Wodak A; Crofts N
Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
[No Abstract] [Full Text] [Related]
18. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus seroprevalence: selected health care settings in Texas.
Melville SK; Heseltine G; Delamater E; Gilani Z; Hendricks K; Suarez L
Tex Med; 2006 Mar; 102(3):56-61. PubMed ID: 17115588
[No Abstract] [Full Text] [Related]
20. Drug abuse treatment as a strategy to prevent human immunodeficiency virus infection among intravenous drug users. How can we maximize prevention of infection?
West AP
Arch Intern Med; 1991 Aug; 151(8):1493-6. PubMed ID: 1651688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
